Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset

OBJECTIVES: The clinical benefit of conventional disease-modifying antirheumatic drugs (cDMARDs) for treating ankylosing spondylitis (AS) is generally limited to improvements in peripheral arthritis. However, cDMARDs could be conditionally considered as alternatives to established drugs for improvin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ther Adv Musculoskelet Dis
Hauptverfasser: Lee, Tae-Han, Koo, Bon San, Nam, Bora, Oh, Ji Seon, Park, Seo Young, Lee, Seunghun, Joo, Kyung Bin, Kim, Tae-Hwan
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2020
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705797/
https://ncbi.nlm.nih.gov/pubmed/33294039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20975912
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge